What Researchers Did
Researchers reviewed the historical development and applications of hyperbaric oxygen therapy in cardiology, including its use in acute myocardial infarction and post-angioplasty.
What They Found
Hyperbaric oxygen (HBO) was initially used at 3 atmospheres with 100% oxygen for decompression sickness and later found to aid wound healing and congenital heart disease surgery. In 1997, HBO therapy was combined with thrombolytics for acute myocardial infarction, and more recently, HBO-saturated saline has been infused into coronary arteries immediately after angioplasty.
What This Means for Canadian Patients
Canadian patients with acute myocardial infarction or those undergoing angioplasty might benefit from hyperbaric oxygen therapy as a complementary treatment to reduce myocardial injury. This therapy could potentially improve outcomes by mitigating reperfusion injury, a significant cause of cell death after coronary artery re-opening.
Canadian Relevance
This study has no direct Canadian connection as it is a historical perspective and personal journey without specific Canadian data or participants.
Study Limitations
As a historical perspective and personal journey, this review does not present new clinical trial data and highlights the need for more research to establish future applications of HBO in cardiovascular disease.